Navigation Links
Plexus Awarded Development Contract With QIAGEN
Date:5/28/2009

NEENAH, Wis., May 28 /PRNewswire-FirstCall/ -- Plexus Corp. (Nasdaq: PLXS) announced today that it has been selected to develop QIAGEN's next generation automated screening system for the pre-processing of human papillomavirus (HPV) DNA samples. This product provides a highly automated solution to a current manual process, through sophisticated robotic motions. QIAGEN is the market leader in DNA based screening for HPV; a virus that has an established link to cervical cancer. This contract for the final development phase builds on the existing collaboration which led to the first prototypes.

"We are thrilled about our partnership with QIAGEN, as it pairs two world-class companies to create an industry leading product," stated Steve Frisch, Sr. Vice President, Global Engineering Services. "Plexus sees this relationship as an indication of how we can utilize our full suite of engineering capabilities, coupled with our complete Product Realization Services, to provide mechatronic solutions for our customers developing complex medical equipment."

"Plexus' proven track record of assisting customers in bringing complex medical devices to market, coupled with its ability to quickly staff this program from its five Global Design Centers, made them an ideal partner," commented Dr. Jim Godsey, Sr. Vice President, North America Research & Development at QIAGEN. "Thanks to this partnership we will be able offer a unique frontend solution for our next generation high through-put screening platform, which will help QIAGEN further maintain its market leadership in the Life Sciences and diagnostics markets."

About Qiagen

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and prote
'/>"/>

SOURCE Plexus Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.
2. Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.
3. Plexus Announces Expansion in Hangzhou, China
4. Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference
5. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
6. Mirus Bio Awarded Grants & Contracts of Over $5 Million
7. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
8. ViPS Awarded Enterprise Systems Development (ESD) Contract By CMS
9. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
10. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
11. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BioConvergence team members Curtis Strother and ... BioLogistics Summit in San Francisco earlier this month. ... IQ and IQPC, addressed the increasingly complex logistical ... attributed to current trends of globalization, outsourcing, and ... is an increase in movement, which is often ...
(Date:6/19/2013)... Diego, CA (PRWEB) June 19, 2013 ... pipettes, Pipette.com is now stocked with Simport’s Dropette® ... all aimed at the customer doing basic biology, chemistry ... work, and serology). , For over 35 years, Simport ... disposable plastic labware - products like the Simport Dropette®. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 ExakTime, ... in North America, has introduced AccountLinx Plus, a ... payroll records between ExakTime’s software and industry-leading payroll ... software setup and keeps employee databases up-to-date in ... a business’ current payroll software, directly into ExakTime’s ...
(Date:6/18/2013)... 2013 Nasseo, Inc. today announces that ... out of hundreds of applicants by the Arizona ... Innovation Challenge . The Arizona Innovation Challenge (AIC) awards ... commercialization challenge, granting a financial award to what it ... Nasseo’s state of the art dental and orthopedic implant ...
Breaking Biology Technology:BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2
... JERSEY CITY, New Jersey, October 29, Rosetta Genomics ... of microRNA-based diagnostics, announced today its,management will present ... 3-4, 2008 at the Waldorf-Astoria Hotel in New ... recently discovered, naturally occurring, small,RNAs that act as ...
... Inverness Medical,Innovations, Inc. (Amex: IMA ), a ... financial results for the quarter,ended September 30, 2008., ... net revenue of,$438.8 million compared to net revenue of ... increase was primarily due to $118.7 million,of incremental revenue ...
... Oct. 29 The Healthcare Scoop,( http://www.healthcarescoop.com ... patient stories about healthcare, will now extend ... organizations, according,to MaryAnn Stump, president, Consumer Aware. ... including Courage Center, Mayo,Clinic, The Emily Program, ...
Cached Biology Technology:Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Inverness Medical Innovations Announces Third Quarter 2008 Results 2Inverness Medical Innovations Announces Third Quarter 2008 Results 3Inverness Medical Innovations Announces Third Quarter 2008 Results 4Inverness Medical Innovations Announces Third Quarter 2008 Results 5Inverness Medical Innovations Announces Third Quarter 2008 Results 6Inverness Medical Innovations Announces Third Quarter 2008 Results 7Inverness Medical Innovations Announces Third Quarter 2008 Results 8Inverness Medical Innovations Announces Third Quarter 2008 Results 9Inverness Medical Innovations Announces Third Quarter 2008 Results 10Inverness Medical Innovations Announces Third Quarter 2008 Results 11Inverness Medical Innovations Announces Third Quarter 2008 Results 12Inverness Medical Innovations Announces Third Quarter 2008 Results 13Inverness Medical Innovations Announces Third Quarter 2008 Results 14Inverness Medical Innovations Announces Third Quarter 2008 Results 15Inverness Medical Innovations Announces Third Quarter 2008 Results 16Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations 2Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations 3
(Date:6/19/2013)... canary seeds bred specifically for human consumption qualifies as ... with celiac disease (CD), scientists have confirmed in a ... Food Chemistry . , Joyce Irene Boye and ... in the United States alone have CD. They develop ... and other grains that contain gluten-related proteins. Boye,s team ...
(Date:6/19/2013)... In fall 2012, the European Medicines Agency (EMA) ... the first ever gene therapy for clinical use ... company, had developed AAV-LPL S447X for the treatment ... lipase deficiency (LPLD) which affects approximately one or ... causes severe, life-threatening inflammations of the pancreas. Afflicted ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... of cardiac therapeutics have long looked to the future when ... one,s own heart cells. A study published in the February ... American Heart Association, shows that heart stem cells from children ... heart in an animal model. ...
... of Exeter has revealed that couples with similar personalities make ... least in the world of zebra finches. Researchers found ... a willingness to explore, did a much better job of ... were markedly different in personality, chicks didn,t fare as well ...
... For the first time, scientists have mapped the genome--the genetic ... efforts to maintain the genetic diversity of captive and wild ... be used to help improve our understanding of the evolution ... National Science Foundation, the orangutan study appears in the Jan. ...
Cached Biology News:Using a child's own stem cells to repair their heart looks promising 2Opposites may attract, but they don't make better parents 2Scientists determine what makes an orangutan an orangutan 2Scientists determine what makes an orangutan an orangutan 3
... Ideal for staining westerns and includes stickers ... Pour spouts in each corner facilitate pouring ... be used for identification. Lid is designed ... for staining several gels simultaneously. Lid also ...
... 20 years of experience in providing versatile ... the Freedom EVO platform delivers even more ... future needs. Together with the new easy-to-use ... to successfully operate genomics, proteomics, and drug ...
... in any standard fixed-angle microcentrifuge rotor ... g.,Spin- centrifuge tube filters consist of ... centrifuge tube. They filter by centrifugation ... sample preparation, removal of cells from ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Material: polystyrene flat ...
Biology Products: